SS-31 10 mg

SS-31 (Elamipretide) is a synthetic, mitochondria-targeted tetrapeptide that selectively associates with cardiolipin within the inner mitochondrial membrane. It is classified as a cell-permeable aromatic-cationic peptide developed as a research tool for investigating mitochondrial bioenergetics, cristae architecture, and electron transport chain organization.

Through high-affinity binding to cardiolipin, SS-31 supports the structural integrity of respiratory chain supercomplexes and preserves cristae morphology under conditions of metabolic or oxidative stress. This targeted interaction has been associated with improved ATP synthesis, reduced reactive oxygen species generation, and protection of mitochondrial membrane potential in cellular and animal research models. Unlike conventional antioxidants that scavenge free radicals after they form, SS-31 is investigated for its ability to stabilize mitochondrial architecture at the source.

SS-31 is actively investigated across several research domains, including cardiac bioenergetics, neurodegeneration research, ischemia-reperfusion stress models, renal cellular-stress research, and age-related mitochondrial decline. Published studies have demonstrated that SS-31 restores mitochondrial energetics in ischemic kidney models and protects cristae structure during reperfusion (Birk et al., 2013, JASN). Its tetrapeptide structure enables rapid cellular uptake and selective localization to the inner mitochondrial membrane without disrupting membrane potential.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Mitochondria are the primary energy-producing organelles within cells and play a central role in oxidative phosphorylation, redox balance, and apoptotic signaling. Disruption of mitochondrial structure, cardiolipin composition, or cristae organization impairs electron transport efficiency, reduces ATP output, and increases oxidative stress. These features are commonly observed in cardiovascular research models, neurodegeneration research, renal cellular-stress models, and age-related functional decline.

SS-31 was developed at the Szeto-Schiller laboratory to directly address these mitochondrial vulnerabilities. Its aromatic, positively charged structure enables rapid cellular uptake independent of receptor binding, with selective concentration in the inner mitochondrial membrane. There it binds cardiolipin, a unique tetra-acyl phospholipid required for cristae formation and respiratory chain supercomplex assembly.

This structural mode of action distinguishes SS-31 from conventional antioxidants and positions it as a frequently used research tool in mitochondrial biology, bioenergetics, and laboratory investigations of energy homeostasis and cellular stress adaptation.

1. Selective Cardiolipin Binding

SS-31 concentrates in the inner mitochondrial membrane through high-affinity interaction with cardiolipin. This binding stabilizes the cardiolipin-cytochrome c complex, supports cristae curvature, and preserves the organization of respiratory chain supercomplexes essential for efficient electron transport.

2. Reduction of Mitochondrial Oxidative Stress

By stabilizing the cardiolipin-cytochrome c interaction, SS-31 limits cytochrome c peroxidase activity, a key driver of cardiolipin peroxidation. This action reduces electron leakage from the respiratory chain and lowers reactive oxygen species generation at the source of mitochondrial oxidant production.

3. Preservation of ATP Synthesis

Maintained cristae architecture and protected supercomplex organization support efficient proton gradient formation and ATP synthase function. SS-31 has been shown to preserve mitochondrial respiration and ATP output in cellular and tissue models exposed to ischemic or metabolic stress.

4. Support of Mitochondrial Quality Control

Research indicates that SS-31 influences mitochondrial dynamics by promoting fusion processes, limiting excessive fission, and supporting mitophagy of damaged mitochondria. These actions contribute to long-term mitochondrial quality control in high-energy-demand tissues.

Research Applications

Conclusion

SS-31 represents a structurally targeted approach to mitochondrial research, acting through selective cardiolipin binding rather than non-specific radical scavenging. By preserving cristae architecture, supporting respiratory chain organization, and limiting cardiolipin peroxidation, SS-31 supports stable mitochondrial bioenergetics across cardiac, renal, neuronal, and aging research models. Its mechanistic specificity makes it a valuable reference compound in mitochondrial biology and bioenergetic research.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.